New migraine treatments have brought stunning relief to many people by blocking the action of calcitonin gene-related peptide (CGRP), a protein in the brain involved in the migraine process.

Additionally, we are conducting the EMERGE study, a multicenter, Phase 3, single-group trial evaluating the efficacy and ...

HEARTBURN drugs could increase your risk of agonising migraines, a study shows. People who take acid reflux meds are more ...

Conditions such as diabetes, heart attack, and vascular diseases commonly diagnosed in people with spinal cord injuries can ...

Conditions such as diabetes, heart attack and vascular diseases commonly diagnosed in people with spinal cord injuries can be traced to abnormal post-injury neuronal activity that causes abdominal fat ...

Discover how Amgen's patent for bispecific antigen binding proteins targeting CGRP and PAC1 receptors could revolutionize treatment for chronic pain, migraines, and cluster headaches. Learn about the ...

A drug that can help prevent migraines could soon be available on the NHS. Atogepant (brand name: Aquipta) was recently ...

BRITAIN’S Got Talent judge Simon Cowell has been slammed by show fans for a “disgusting” habit. The ITV series’ head honcho, ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Citi analyst Andrew Baum, after covering Pfizer for more than a decade, will join the Big Pharma company as chief strategy and innovation officer. In the role, he'll oversee the drugmaker's portfolio ...

Total 1Q 2024 net product revenue of $75.0 million, representing 160% year-over-year growthAuvelity® 1Q 2024 net product sales of $53.4 million, ...

A calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against ...